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doi:10.1Objectives: The purpose of this study was to examine the trends in tricuspid valve surgery over time.
Methods:We used 10 years (1999-2008) of NIS data to examine the population of patients undergoing tricuspid
valve repair or replacement (ICD-9-CM codes 35.14, 35.27, and 35.28).
Results:We identified 28,726 admissions for tricuspid valve surgery. The total number of tricuspid procedures
more than doubled over the 10- year period (1712 cases in 1999 vs 4072 cases in 2008). Although the absolute
number of repairs and replacements increased over time, the tricuspid repair rate increased whereas there was
a corresponding decrease in tricuspid replacement rate. Isolated tricuspid valve surgery accounted for 20% of
the total tricuspid cases, whereas tricuspid surgery as a concomitant procedure to other cardiac operations
accounted for the remaining 80%. There was a trend toward increased use of tissue over mechanical valves
for tricuspid replacement. Overall hospital mortality was 10.6%. Over time, mortality decreased significantly
for both repair and replacement. Concomitant tricuspid replacement was associated with significantly higher
hospital mortality than was isolated tricuspid replacement (16.1% vs 10.1%; P ¼ .0001).
Conclusions: There has been a dramatic increase in tricuspid interventions over time. This has been associated
with an increase in tricuspid repair rates as well as use of bioprostheses for tricuspid replacement. The majority
of tricuspid operations are performed concomitantly to other cardiac procedures. Mortality for tricuspid valve
surgery remains considerable and significantly higher for replacement than for repair. (J Thorac Cardiovasc Surg
2012;143:1043-9)Significant advances in surgical care for patients with val-
vular heart disease have taken place in the United States
over the recent past. Within the area of mitral valve surgery,
there has been an increased use of repair as the preferred
surgical approach for the correction of mitral valve dis-
ease.1 In the area of aortic valve disease, outcomes have
shown considerable improvement with decreased mortality
and major perioperative morbidity.2 Tricuspid valve (TV)
surgery is performed much less often than surgery on the
mitral or aortic valves. Consequently, published reports
have been limited by small numbers, typically from single
institutions. In addition, there has been ongoing debate re-
garding the optimal surgical approach for TV disease (re-
pair vs replacement)3,4 and type of prosthesis used
(mechanical vs bioprosthesis).5 The purpose of our investi-
gation was to review the trends in demographics, case mix,
procedure selection, and hospital outcomes of patientse Division of Cardiothoracic Surgery, Southern Illinois University School of
cine, Springfield, Ill.
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The Journal of Thoracic and Carundergoing TV surgery over the period from 1999 to
2008 using data from the largest all-payer database in the
United States, the Nationwide Inpatient Sample (NIS),
Healthcare Cost and Utilization Project (HCUP), Agency
for Healthcare Research and Quality.METHODS
Database
TheNIS is a stratified probability sample developed as part of the HCUP
funded by the Agency for Healthcare Research and Quality. It includes data
from roughly 20% of hospital admissions in the United States. So that sam-
pling bias can be minimized, the NIS is stratified by geographic region, ur-
ban versus rural location, teaching status, and hospital bed size. In other
words, hospitals are divided into homogeneous subgroups with respect to
these characteristics. For example, if a random 20% sample of hospital ad-
missions is obtained, there may be an overrepresentation of urban hospitals
or hospitals from certain geographic regions with a corresponding under-
representation of rural hospitals or hospitals from other geographic regions.
With a stratified probability sample, hospitals within each of the different
strata in the overall sample have an equal probability representation in the
selected 20% sample. The data are weighted to represent the entire inpa-
tient population. The database contains deidentified patient data including
up to 15 procedure and 15 diagnostic codes according to the International
Classification of Diseases, Ninth Edition, Clinical Modification (ICD-9-
CM). The NIS is the largest all-payer database and is used for analysis
of trends in health care utilization, access, charges, quality, and outcomes
for both research and policy-making purposes (HCUP databases). The NIS
shares many similarities with the Medicare database, including the same
ICD-9-CM coding system for procedures and diagnoses. Unlike the Medi-
care database, however, which includes data on a single payer and as a result
tends to include patients 65 years or older, the NIS includes all payers anddiovascular Surgery c Volume 143, Number 5 1043
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
HCUP ¼ Healthcare Cost and Utilization Project
ICD-9-
CM
¼ International Classification of Diseases,
Ninth Edition, Clinical Modification
NIS ¼ Nationwide Inpatient Sample
TV ¼ tricuspid valve
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erages across the United States. In addition, the NIS also includesMedicare
Advantage patients, a population that is missing fromMedicare claims data
but that comprises as much as 20 percent of Medicare beneficiaries.
The study was granted exempt status by our institutional review board.
Sample Selection
The NIS database was searched from 1999 to 2008 to identify patients
with TV repair (ICD-9-CM code 35.14) or replacement (ICD-9-CM co-
des 35.27 and 35.28). Patients less than 30 years of age and those with
congenital heart disease were excluded. The final patient population con-
sisted of 5808 observations representing 28,726 admissions for TV
surgery (after appropriate weighting). Data are reported as number of
admissions.
Statistical Analysis
Descriptive statistics including frequencies, percents, means, medians,
and interquartile ranges are presented. Group comparisons were carried
out using c2 tests of independence, independent groups t tests, and median
tests. Cochran-Armitage tests were used to test for trends across the years.
All analyses were performed using SAS version 9.2 which allows for
weighting to reflect the stratified sampling scheme used in the NIS (SAS
Institute Inc, Cary, NC).RESULTS
Patient and Hospital Characteristics
Patient and hospital demographics are shown in Table 1.
Patients undergoing repair were older than those undergo-
ing replacement (median age, 69 years vs 61 years;
P<.0001). Of the entire cohort, 61.3% were female and
71.9% were white, with no significant difference between
the repair and replacement subsets. A substantial number
of patients (42.5%) were referred for TV surgery nonelec-
tively. Patients in the replacement group more often were
referred nonelectively (P<.0001). Moreover, the incidence
of endocarditis was significantly higher in the replacement
than in the repair group (14.5% vs 6.6%; P ¼ .0001). Ex-
amination of comorbidities between the repair and replace-
ment subsets revealed no significant differences between
the 2 groups with respect to congestive heart failure, periph-
eral vascular disease, cerebrovascular disease, and renal
disease. Patients undergoing repair more often had diabetes
(P ¼ .0229), pulmonary disease (P ¼ .0001), and a history
of myocardial infarction (P ¼ .0011), whereas patients
undergoing replacement more often had liver disease
(P ¼ .0001).1044 The Journal of Thoracic and Cardiovascular SurThe majority of the TV operations (98.5%) were per-
formed in urban hospitals, and 72.5% were performed in
teaching hospitals. A greater proportion of replacements
(77.4%) were performed in teaching hospitals than repairs
(70.7%; P ¼ .0023). When broken down by region,
22.5% of the total procedures were performed in the North-
east, 25.4% in the South, 32.4% in theMidwest, and 19.7%
in the West. A higher proportion of patients from the South
underwent repair (P¼ .0137) and a higher proportion of pa-
tients from the West underwent replacement (P ¼ .0023).
The number of TVoperations increasedwith increasing hos-
pital bed size. For example, 79.0% of operations were
performed in large hospitals whereas only 3.9% were
done in small hospitals. However, there was no significant
difference between the repair and replacement groups with
respect to hospital bed size.
Trends in Case Mix
TV repair versus replacement. The total number of ad-
missions for TV operations from 1999 to 2008 was
28,726. Of these, 72.9% (20,951/28,726) were repairs and
27.1% (7775/28,726) were replacements (Figure 1, A).
The total number of TV procedures more than doubled
over the 10-year period (1712 cases in 1999 vs 4072 cases
in 2008). When stratified by procedure type, although the
absolute number of both repair and replacement operations
increased over time (Figure 1, A), the TV repair rate in-
creased whereas there was a corresponding decrease in
TV replacement rate (P ¼ .0001) (Figure 1, B).
Bioprosthetic versus mechanical TV replacement.
Overall, tissue valves were used in 46.1% (3586/7775) of
TV replacements with mechanical valves accounted for
the remaining 53.9% (4189/7775). Using the Cochran-
Armitage tests for trends across the years, there was a trend
toward increased use of tissue over mechanical valves for
TV replacement (P¼ .0001). Although the absolute number
of bioprosthetic and mechanical TV replacements increased
over time (Figure 2, A), bioprosthesis use increased from
34.9% in 1999 to 53.8% in 2008 (P<.0001), whereas the
use of mechanical prostheses diminished from 65.1% in
1999 to 46.2% in 2008 (P<.0001) (Figure 2, B).
Isolated versus concomitant TV surgery. Isolated TV
surgery accounted for 20.0% (5736/28,726) of the total tri-
cuspid cases, whereas TV surgery as a concomitant proce-
dure to other cardiac operations accounted for the
remaining 80.0%. Within the subset of TV repair, 11.8%
of the cases were isolated and 88.2% were concomitant to
other cardiac procedures. Using the Cochran-Armitage tests
for trends across the years, there was a trend toward
a decreasing rate of isolated TV repairs over time, with
a corresponding increasing rate of TV repair performed con-
comitantly (P¼ .0001) (Figure 3, A). Further trend analysis
of TV repair performed as a concomitant procedure revealed
an increased rate of TV repair in the setting of mitral repairgery c May 2012
TABLE 1. Characteristics of patients undergoing TV surgery from 1999 to 2008 according to NIS database
Overall Repair Replacement P value
No. of patients 28,726 20,951 (73%) 7775 (27%)
Age: mean, median (IQR) 64.4, 67 (54-76) 66.0, 69 (57-76) 59.9, 61 (48-73) <.0001
Female 17,621 (61%) 12,918 (62%) 4703 (60%) .3931
White 14,856 (72%) 10,891 (73%) 3965 (69%) .1014
Urban 17,134 (85%) 12,786 (85%) 4348 (86%) .3203
Admission status <.0001
Elective 14,621 (58%) 11,104 (60%) 3517 (52%)
Urgent/emergency 10,823 (42%) 7523 (40%) 3300 (48%)
Comorbidities
Previous MI 1541 (5%) 1254 (6%) 287 (4%) .0011
CHF 12,964 (45%) 9304 (44%) 3660 (47%) .1209
PVD 911 (3%) 732 (4%) 180 (2%) .0645
CVA 1256 (4%) 941 (4%) 315 (4%) .4666
Pulmonary disease 5030 (18%) 3925 (19%) 1105 (14%) .0001
Liver disease 524 (2%) 240 (1%) 284 (4%) .0001
Diabetes 4437 (15%) 3373 (16%) 1064 (14%) .0229
Renal disease 2346 (8%) 1701 (8%) 645 (8%) .8262
Endocarditis 2508 (8.7%) 1379 (6.6%) 1129 (14.5%) .0001
Hospital characteristics
Teaching hospitals 20,827 (72%) 14,813 (71%) 6014 (77%) .0023
Region
Northeast 6458 (22%) 4542 (22%) 1916 (25%) .0044
South 7305 (25%) 5704 (27%) 1661 (21%)
Midwest 9300 (32%) 6898 (33%) 2402 (31%)
West 5664 (20%) 3807 (18%) 1856 (24%)
Bed size
Small 1125 (4%) 861 (4%) 263 (3%) .4304
Medium 4907 (17%) 3667 (18%) 1240 (18%)
Large 22,695 (79%) 16,423 (78%) 6272 (81%)
TV, Tricuspid valve; NIS, Nationwide Inpatient Sample; IQR, interquartile range; MI, myocardial infarction; CHF, congestive heart failure; PVD, peripheral vascular disease;
CVA, cerebrovascular accident.
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(P ¼ .0001), as well as TV repair in the setting of isolated
aortic valve replacement (P¼ .0464) (Figure 3, B), whereas
there was a decreasing trend of TV repair performed in the
setting of mitral replacement with or without CABG
(P ¼ .0001), as well as TV repair in the setting of double
valve (aortic and mitral) replacement (P ¼ .0007)
(Figure 3, C). Within the subset of TV replacement, 3271
(42.1%) of 7775 cases were isolated, whereas 4504
(57.9%) of 7775were concomitant. Therewere significantly
more isolated cases in the replacement subset than in the re-
pair subset (42.1% vs 11.8%; P¼ .0001). Therewas a trend
toward increasing rate of isolated TV replacement over time,
with a corresponding decreasing rate of TV replacement per-
formed as a concomitant procedure (P ¼ .0001) (Figure 3,
D). The majority (2591/4504, 57.5%) of TV replacements
performed concomitantly were in the setting of mitral valve
replacement with or without CABG.
Hospital Mortality
Overall hospital mortality for patients undergoing TV
surgery was 10.6%. Over time, mortality decreasedThe Journal of Thoracic and Carsignificantly for both repair and replacement (P ¼ .0001)
(Figure 4). Hospital mortality for TV replacement was sig-
nificantly higher than for TV repair (13.6% vs 9.5%;
P ¼ .0001). There was no difference in hospital mortality
for patients undergoing bioprosthetic versus mechanical
TV replacement (14.2% vs 13.0%; P ¼ .5023). Overall
hospital mortality for isolated TV surgery was 9.0% com-
pared with 11.0% for concomitant TV surgery
(P ¼ .0520). Over time, mortality for isolated TV surgery
did not change significantly (P ¼ .3884) whereas mortality
for concomitant TV surgery decreased slightly (P<.0001).
For the TV repair subset, isolated repair mortality was 7.6%
compared with 9.8% for repair performed concomitantly
(P ¼ .1438). Isolated TV replacement was associated
with significantly lower hospital mortality than was TV re-
placement performed concomitantly with other cardiac pro-
cedures (10.1% vs 16.1%; P ¼ .0001).
Influence of liver disease on mortality. Because the pro-
portion of subjects with liver disease was lower in the repair
than in the replacement group (1% vs 4%; P ¼ .0001), we
specifically compared mortality of patients with or without
liver disease stratified by procedure type. The presence ofdiovascular Surgery c Volume 143, Number 5 1045
FIGURE 1. Trends in tricuspid valve operations from 1999 to 2008 ac-
cording to the NIS database: A, Total number of tricuspid admissions
over time. B, Rates of tricuspid repair and replacement over time.
FIGURE 2. Trends in tricuspid valve replacement from 1999 to 2008 ac-
cording to NIS database: A, Total number of tricuspid replacements over
time. B, Rates of bioprosthesis versus mechanical tricuspid valve replace-
ment over time.
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tality both for patients undergoing repair (22.85% [55/240]
vs 9.37% [1938/20,684]; P¼ .0011) and for those undergo-
ing replacement (27.04% [77/284] vs 13.07% [977/7476];
P ¼ .0033). Consequently, the difference in mortality be-
tween the repair and replacement groups was no longer sta-
tistically significant among the subset of patients with liver
disease undergoing TV surgery (22.85% [55/240] vs
27.04% [77/284]; P ¼ .6225). When we compared mortal-
ity for repair versus replacement among patients without
liver disease, mortality for replacement remained signifi-
cantly higher (13.07% [977/7476] vs 9.37% [1938/
20,684]; P ¼ .0001).
Length of stay. Median length of stay for TV repair was
significantly less than for replacement (12 days vs 15
days; P ¼ .0001). Furthermore, within the repair subset,
there was no difference in median length of stay for isolated
versus concomitant procedures (11 days vs 12 days;
P ¼ .4283). Within the replacement subset, median length
of stay for bioprosthetic and mechanical valves was similar
(14 days vs 15 days; P¼ .4497) as it was for isolated versus
concomitant TV replacement (15 days for both).
Length of stay was initially examined as a continuous
outcome but, because of distributional characteristics, was
subsequently dichotomized using a median split (length of
stay, 12 days). Therefore, prolonged hospitalization was de-
fined as length of stay equal to or greater than 12 days.1046 The Journal of Thoracic and Cardiovascular SurOverall, there was an increasing trend of prolonged hospi-
talization over time for both the repair (P< .0001) and
replacement (P<.0001) subsets.
Pacemaker implantation. Overall, pacemaker implanta-
tion occurred in 11.6% of the patients undergoing TV valve
surgery. As expected, the need for a postoperative pace-
maker was significantly higher in the replacement group
than in the repair group (17.2% vs 9.5%; P ¼ .0001).
DISCUSSION
Despite recent advances in cardiac surgery, TV interven-
tion remains associated with high morbidity and mortality.6
Considering that TV surgery is relatively rare, many previ-
ous series come from high-volume institutions and may not
be an accurate depiction of national trends. Therefore, we
undertook this investigation to analyze the trends in demo-
graphics, case mix, procedure selection, and hospital out-
comes of patients undergoing TV surgery over the period
from 1999 to 2008 using data from the NIS. The NIS data-
base is the largest all-payer database in the United States
and has been used extensively for analysis of trends in
health care utilization, access, charges, quality, and out-
comes for both research and policy making (HCUP
databases).
Consistent with the decreasing mortality for aortic and
mitral valve surgery, we found a similar trend in TV surgery.gery c May 2012
FIGURE 3. Trends in isolated versus concomitant tricuspid surgery from
1999 to 2008 according to the NIS database: A, Trends in isolated versus
concomitant tricuspid valve repair. B, Increasing trends of tricuspid repair
performed concomitantly. C, Decreasing trends in concomitant procedures
with tricuspid repair. D, Trends in isolated versus concomitant tricuspid
valve replacement over time. CABG, Coronary artery bypass grafting.
FIGURE 4. Trends in tricuspid mortality over time.
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across the 10-year period, it was significantly higher for re-
placement than for repair. It appears that this difference inThe Journal of Thoracic and Carmortality is primarily driven by the higher mortality of con-
comitant TV replacement in the setting of other cardiac pro-
cedures (more than half of these being concomitant mitral
valve replacement with or without CABG). Lower mortality
for repair versus replacement has also been reported in mi-
tral valve surgery.7-9 Althoughwithin the subset of TV repair
there was no difference with respect to mortality of isolated
versus concomitant procedure, in the TV replacement
subset, concomitant procedures had significantly higher
mortality than did isolated TV replacement (16.1% vs
10.1%). Consequently, this identifies an important area for
future improvement in the care of patients with valvular
heart disease.
Compared with aortic and mitral valve surgery, TV sur-
gery remains associated with significantly higher mortality.
Filsoufi and associates10 reported a 22% mortality for
a small heterogeneous series of 81 patients undergoing
TV replacement. In their series, 72% of the cases were re-
operations.10 Ratnatunga and colleagues11 showed a 17.3%
30-day mortality for a series of patients from the United
Kingdom valve registry, and Kaplan and associates5 re-
ported an overall hospital mortality of 24.5%. Our overall
hospital mortality is lower than what has been reported by
others. Several explanations exist for this discrepancy. Be-
cause our mortality for concomitant TV replacement was
significantly higher than that for isolated replacement, dis-
crepancy in results may be due to differences in relative pro-
portions of patients with isolated versus concomitant
surgery in different series. Furthermore, results from vari-
ous authors may vary depending on the cause of TV disease.
For example, Singh and coworkers3 studied a group of 250
patients who underwent TV surgery for organic valve dis-
ease from 1979 to 2003. This group (not separated by iso-
lated or concomitant) had a hospital mortality rate of 4%
for TV repair and 22% for TV replacement. In contrast,
mortality for TV replacement for carcinoid heart disease
has been reported as high as 63%.12 The overall hospital
mortality rate for TV surgery performed on 328 patients
with rheumatic disease was 6.4% for repair and 19.3%
for replacement,13 whereas TV surgery concomitantlydiovascular Surgery c Volume 143, Number 5 1047
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mortality rate of 8.1%.14
The presence of liver disease confers an excessive risk of
mortality in TV surgery (>20%), regardless of procedure
selection (repair vs replacement). Although in the group
of patients undergoing replacement the incidence of liver
disease was higher, it appears that the difference in mortal-
ity between the repair and replacement groups is only partly
explained by the higher incidence of liver disease in the re-
placement group. The difference in mortality rates between
repair and replacement for those without liver dysfunction
was 3.7% whereas the difference for those with liver dys-
function was 4.19%. Others have used The Model for
End-Stage Liver Disease score to stratify patients with liver
disease undergoing TV surgery and found that this score
predicts mortality in this subset of patients and may be
used as a simple method for risk stratification.15
Published TV repair series typically have included either
patients with isolated TV disease or patients undergoing
other cardiac procedures, such as mitral valve surgery, dur-
ing which TV repair was performed as a concomitant pro-
cedure. Our investigation provides the largest series
comparing trends and outcomes for these 2 subsets of
patients. We found that there was an overall increase in con-
comitant TV repair over time in our case mix. We further
analyzed this overall trend and found an increased number
of TV repairs performed concomitantly with mitral repair
with or without CABG. This is consistent with recent liter-
ature, suggesting that there is a specific subset of patients
with TV regurgitation of even moderate degree in the
setting of mitral valve disease that may benefit from TV in-
tervention.16,17 Furthermore, the TV disease in these cases is
often amenable to repair.16,17 Because the NIS database
contains discharge data only from the initial hospitalization,
longitudinal follow-up studies are needed to examine how
an increase in TV repairs affects long-term repair durability
and survival. Although within the NIS database we cannot
establish the cause of TV disease (functional vs organic), it
appears that the increasing trend of concomitant TV repair,
especially in the setting of mitral valve surgery, reflects
a more aggressive approach to TV disease. Consequently,
TV repairs performed concomitantly withmitral replacement
with or without CABG were shown to decrease over time.
This finding is consistent with the general trend of increasing
valve repair over replacement as the procedure of choice for
surgical correction of mitral valve disease.7 The advantages
of mitral repair over replacement have been widely estab-
lished.7 Similar to this trend in mitral surgery, we found that
there was a significant increase in TV repair rates over time,
with a corresponding decrease in the rates of replacement.
TV regurgitation is a widely known sequela of long-
standing mitral valve disease. Consequently, inasmuch as re-
cent guidelines on the management of valvular heart disease
recommendearlier interventionon themitral valve, theremay1048 The Journal of Thoracic and Cardiovascular Surbe a corresponding decrease in secondary TV disease in the
future.18
In contrast to the trend in TV repair, we found a decreas-
ing trend of concomitant TV replacement. Interestingly, the
majority of these were performed in the setting of mitral
valve replacement with or without CABG. It is possible
that mitral disease not amenable to repair is associated
with a corresponding TV disease also not amenable to re-
pair. The NIS database does not provide detailed informa-
tion of the etiology (eg, degenerative vs rheumatic) or
type (stenosis vs regurgitation) of organic TV disease, lim-
iting our ability to draw any definite conclusions with re-
spect to this finding. Certainly, in the overall population,
the presence of endocarditis appears to increase the risk
of undergoing replacement.
Multiple investigations have addressed the ongoing de-
bate with respect to the ideal type of prosthesis in the tricus-
pid position, showing similar long-term survival, reoperation
rates, and valve-related complications.5,10,19,20 In agreement
with previously published literature, we found similar length
of stay and mortality for bioprosthetic and mechanical
valves. Nevertheless, there was a significant increase in
the use of bioprosthetic valves from 34.9% in 1999 to
53.8% in 2008. This finding is likely due to the body of
literature establishing equivalence between bioprosthetic
and mechanical valves, therefore offering the opportunity
to avoid anticoagulation-related complications. This is
consistent with the finding that there was an increasing
trend of isolated TV replacement, as choice of prosthesis
during concomitant TV replacement may be determined
by the need for anticoagulation with respect to the primary
surgical indication.
Our study has several limitations. The NIS is a stratified
probability sample of state inpatient databases including
data on roughly 20% of hospital admissions in the United
States. Therefore, our data were weighted to make them
more applicable to the entire inpatient population. The pur-
pose of administrative databases is to gather data for billing
purposes and can be limited by erroneous coding. However,
the HCUP quality control measures should minimize these
possibilities (HCUP databases). Furthermore, the hard clin-
ical end points used in our analysis are difficult to miscode.
There are several unaccounted for factors that may have
influenced surgeon decision to perform TV repair versus re-
placement. These include information regarding right
ventricular function, pulmonary hypertension, functional
versus organic TV disease, regurgitation versus stenosis as
the indication for surgery, and severity of regurgitation, espe-
cially for TV repair or replacement performed concomitantly
with other cardiac procedures. Nevertheless, we provide the
largest series of TV surgery, including comparisons on repair
versus replacement, isolated versus concomitant surgery, and
bioprosthetic versus mechanical TV replacement. The NIS
database only contains data on the initial hospitalizationgery c May 2012
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mation is not available. Consequently, our study cannot com-
ment on long-term survival after TV surgery, reoperation
rates, and/or TV repair durability.
Several strengths are noted with respect to data from the
NIS. Participation is not voluntary and sampling is
weighted to reflect national averages. Furthermore, the
NIS is the largest all-payer database in the United States
and some of its limitations are offset by large patient vol-
umes, hard clinical end points, and the opportunity to ex-
plore real world community data, making our findings
widely applicable across hospitals in the United States.
We thank Joshua DiGennaro for assistance with manuscript
table and figure preparation and Jean Long for assistance with
manuscript submission and editing.
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